Cargando…

A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia

INTRODUCTION: Ketamine is an agent broadly used for pediatric procedural sedation and analgesia in emergency departments. It has been found to be safe and with a low risk of complications. Choosing between intravenous (IV) and intramuscular (IM) injections is a matter of concern, so we did a compari...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharavifard, Mohammad, Boroumand Reza Zadeh, Behnaz, Zamani Moghadam, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Beheshti University of Medical Sciences 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614599/
https://www.ncbi.nlm.nih.gov/pubmed/26495383
_version_ 1782396408298471424
author Gharavifard, Mohammad
Boroumand Reza Zadeh, Behnaz
Zamani Moghadam, Hamid
author_facet Gharavifard, Mohammad
Boroumand Reza Zadeh, Behnaz
Zamani Moghadam, Hamid
author_sort Gharavifard, Mohammad
collection PubMed
description INTRODUCTION: Ketamine is an agent broadly used for pediatric procedural sedation and analgesia in emergency departments. It has been found to be safe and with a low risk of complications. Choosing between intravenous (IV) and intramuscular (IM) injections is a matter of concern, so we did a comparison between the two methods in terms of their efficacy and rate of complications. METHODS: This single-blind clinical trial recruited 240 children (age: three months to 15 years, weight > 5 kg), who underwent short and painful procedures at the emergency departments. They were randomly allocated to two groups of 120 patients to receive either IV or IM ketamine with of 1.5 and 4 mg/kg doses, respectively. Indications for use, dose, side effects, and efficacy of the medications as well as duration of the procedure and time to recovery were compared between the two groups. RESULTS: The mean age of the IV and IM groups were 6.5 ± 3.6 and 3.05 ± 2.6 years, respectively (p < 0.001). The onset of action of ketamine was 1.7 ± 1.1 minutes in the IV group and 8.6 ± 3.1 in the IM ones (p < 0.001). Patients of the IV and IM groups remained in optimal sedation for 20.6±12.0 and 37.2±11.8 minutes, respectively (P < 0.001). Time until emergency department discharge was 65.3 ± 36.9 minutes in the IV group and 72.2 ± 14.5 in the IM group (P = 0.40). Ketamine had excellent and moderate efficacy in 66.7% and 32.5% of the IV group and 70.0% and 25.0% in the IM group, respectively (p = 0.02). Totally, 60.0% of IV group patients and 40.0% of IM group experienced drug side effects (p = 0.21). Need for rescue dose was significantly higher in IV group (26.7% vs. 10.0%; p < 0.001). Finally, recovery was tranquil and comfortable in 88 patients (73.3%) of the IV group and 108 patients (90.0%) of the IM group (p = 0.06). CONCLUSION: We found that although the sedative and analgesic effects of IM and IV ketamine are not significantly different, duration of effect and onset of action are more desirable in the IV group for suturing, fracture reduction, and foreign body removal. Meanwhile, the IM method can lead to lesser need of rescue doses.
format Online
Article
Text
id pubmed-4614599
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Shahid Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-46145992015-10-22 A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia Gharavifard, Mohammad Boroumand Reza Zadeh, Behnaz Zamani Moghadam, Hamid Emerg (Tehran) Original Research INTRODUCTION: Ketamine is an agent broadly used for pediatric procedural sedation and analgesia in emergency departments. It has been found to be safe and with a low risk of complications. Choosing between intravenous (IV) and intramuscular (IM) injections is a matter of concern, so we did a comparison between the two methods in terms of their efficacy and rate of complications. METHODS: This single-blind clinical trial recruited 240 children (age: three months to 15 years, weight > 5 kg), who underwent short and painful procedures at the emergency departments. They were randomly allocated to two groups of 120 patients to receive either IV or IM ketamine with of 1.5 and 4 mg/kg doses, respectively. Indications for use, dose, side effects, and efficacy of the medications as well as duration of the procedure and time to recovery were compared between the two groups. RESULTS: The mean age of the IV and IM groups were 6.5 ± 3.6 and 3.05 ± 2.6 years, respectively (p < 0.001). The onset of action of ketamine was 1.7 ± 1.1 minutes in the IV group and 8.6 ± 3.1 in the IM ones (p < 0.001). Patients of the IV and IM groups remained in optimal sedation for 20.6±12.0 and 37.2±11.8 minutes, respectively (P < 0.001). Time until emergency department discharge was 65.3 ± 36.9 minutes in the IV group and 72.2 ± 14.5 in the IM group (P = 0.40). Ketamine had excellent and moderate efficacy in 66.7% and 32.5% of the IV group and 70.0% and 25.0% in the IM group, respectively (p = 0.02). Totally, 60.0% of IV group patients and 40.0% of IM group experienced drug side effects (p = 0.21). Need for rescue dose was significantly higher in IV group (26.7% vs. 10.0%; p < 0.001). Finally, recovery was tranquil and comfortable in 88 patients (73.3%) of the IV group and 108 patients (90.0%) of the IM group (p = 0.06). CONCLUSION: We found that although the sedative and analgesic effects of IM and IV ketamine are not significantly different, duration of effect and onset of action are more desirable in the IV group for suturing, fracture reduction, and foreign body removal. Meanwhile, the IM method can lead to lesser need of rescue doses. Shahid Beheshti University of Medical Sciences 2015 /pmc/articles/PMC4614599/ /pubmed/26495383 Text en © 2015 Shahid Beheshti University of Medical Sciences. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), (http://creativecommons.org/licenses/by-nc/3.0/)which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Research
Gharavifard, Mohammad
Boroumand Reza Zadeh, Behnaz
Zamani Moghadam, Hamid
A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia
title A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia
title_full A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia
title_fullStr A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia
title_full_unstemmed A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia
title_short A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia
title_sort randomized clinical trial of intravenous and intramuscular ketamine for pediatric procedural sedation and analgesia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614599/
https://www.ncbi.nlm.nih.gov/pubmed/26495383
work_keys_str_mv AT gharavifardmohammad arandomizedclinicaltrialofintravenousandintramuscularketamineforpediatricproceduralsedationandanalgesia
AT boroumandrezazadehbehnaz arandomizedclinicaltrialofintravenousandintramuscularketamineforpediatricproceduralsedationandanalgesia
AT zamanimoghadamhamid arandomizedclinicaltrialofintravenousandintramuscularketamineforpediatricproceduralsedationandanalgesia
AT gharavifardmohammad randomizedclinicaltrialofintravenousandintramuscularketamineforpediatricproceduralsedationandanalgesia
AT boroumandrezazadehbehnaz randomizedclinicaltrialofintravenousandintramuscularketamineforpediatricproceduralsedationandanalgesia
AT zamanimoghadamhamid randomizedclinicaltrialofintravenousandintramuscularketamineforpediatricproceduralsedationandanalgesia